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Abstract
This overview describes and illustrates the clinical applications of three-dimensional transvaginal
sonography in reproductive medicine. Its main applications include assessment of uterine
anomalies, intrauterine pathology, tubal patency, polycystic ovaries, ovarian follicular monitoring
and endometrial receptivity. It is also useful for detailed evaluation of failed and/or ectopic
pregnancy. Three-dimensional color Doppler sonography provides enhanced depiction of uterine,
endometrial, and ovarian vascularity.
Background
Conventional sonography provides two-dimensional
views of three-dimensional structures that an experienced
ultrasonographer has to dynamically examine in order to
create their own three-dimensional impression of the
object of interest [1]. In contrast, three-dimensional
sonography allows the simultaneous assessment of indi-
vidual sectional planes, which dependent upon the partic-
ular field of interest may be examined in one of several
different viewing modalities to maximise the information
available and improve spatial awareness (Fig. 1) [2,3].
Uniquely, three-dimensional sonography allows demon-
stration of the coronal plane perpendicular to the trans-
ducer face facilitating the identification of surface
irregularities which can then be accounted for during vol-
ume measurement [4]. The digital technology central to
its development also means that three-dimensional imag-
ing lends itself to telemedicine, as it allows the storage of
large datasets without loss of information that may be
subsequently analysed off-line and reappraised by experts
in a 'virtual real-time consultation' [5]. Two-dimensional
color Doppler sonography provides a subjective estima-
tion of uterine and ovarian vascularity. It is limited, how-
ever, by providing flow depiction in a single plane as
opposed to the sample volume as obtained by three-
dimensional imaging (Fig. 1). Advocates of three-dimen-
sional sonography [6] suggest that these features offer the
user the following advantages in comparison to two-
dimensional sonography:
• accurate measurement of organ dimensions and
volumes
• improved anatomic and blood flow information
• improved assessment of complex anatomic anomalies
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Two-dimensional vs three-dimensional transvaginal color Doppler sonography Figure 1
Two-dimensional vs three-dimensional transvaginal color Doppler sonography. (a) Diagram (left) and two-dimensional TV-
CDS (right) showing arcuate, radial, and spiral vessels in follicular phase. (b) Diagram (left) are two-dimensional TV-CDS (right) 
showing changes in endometrial vascularity throughout the menstral cycle. During the luteal phase, several spiral vessels are 
detected. (c) Diagram (top) and multiplanar images (left) and magnified 3D TV-CDS (right) of corpus luteum. The multiplanar 
image shows the vascular "wreath" surrounding the functioning corpus luteum in the longitudinal (top left), short (axial) (top 
right) and coronal (bottom right) planes. The combined gray scale and 3D TV-CDS image (both left) which is also magnified 
and shown as the right depicts the numerous vessels surrounding this corpus luteum.Journal of Experimental & Clinical Assisted Reproduction 2005, 2:10 http://www.jexpclinassistreprod.com/content/2/1/10
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• a better specificity in regard to the confirmation of
normality
• standardisation of the sonographic examination
procedure
• reduced scanning times with cost-effective use of equip-
ment and sonographer time
• telemedicine and tertiary consultation
This review will critically appraise the evidence to see if
the potential advantages of three-dimension over two-
dimension may be substantiated in the context of repro-
ductive medicine and specifically ask if they actually lead
to an improved diagnostic capability. To begin it is first
necessary to outline how three-dimensional sonography
may be used to quantify volume and blood flow as these
measurements form the basis of many studies.
Three-dimensional Data Analysis
When one thinks of three-dimensional imaging in terms
of its measurement capability the most obvious parameter
considered is that of volume. Whilst volume may be esti-
mated from measurements made with conventional two-
dimensional sonography, such measurements use various
formulae based upon certain geometric assumptions [7].
Volume estimation based on three-dimensional sonogra-
phy still involves a degree of geometric assumption, as
data are reconstructed based upon their most probable
position within a Cartesian grid system, but utilises much
more information. There are two basic methods
employed to calculate volume from a three-dimensional
dataset: the conventional 'full planar' or 'contour' method
(Fig. 2a) and the more recently introduced 'rotational'
method possible through the VOCAL-imaging program
(Virtual Organ Computer-aided AnaLysis™) (Fig. 2b)
which also generates a three-dimensional model of the
object of interest (Fig. 3). Volume calculation by either of
these techniques has proven highly reliable and valid
both in vitro and in vivo [8-15]. Both techniques involve
the manual delineation of the object of interest in the
multiplanar display that shows the three perpendicular
planes characteristic of three-dimensional sonography
but there are other advantages to the 'rotational' tech-
nique in that it facilitates assessment of blood flow in a
novel manner through the quantification of the power
Doppler signal both within the defined volume of interest
and also within the surrounding tissue through the appli-
cation of a shell parallel to the originally defined surface
contour (Fig. 4). Three indices of vascularity are calcu-
lated: the Vascularisation Index (VI) reflects the ratio of
power Doppler information within the total dataset rela-
tive to both colour and grey information, the Flow Index
(FI) represents the mean power Doppler signal intensity
and the Vascularisation Flow Index represents a combina-
tion of the two (Fig. 5) [16]. The exact relationship of
these indices to true flow and vascularity in vivo remains
to be established but they have been shown to vary both
within an individual and between different subjects sug-
gesting they could have a valuable role in identifying and
categorising differences between patient groups (Fig. 6).
Importantly, the indices may be calculated in a reproduc-
ible manner between observers [17] following the three-
dimensional acquisition of power Doppler data which
itself has also been shown to be reliable [18].
Clinical applications of three-dimensional 
sonography
Having established the key features of three-dimensional
sonography in terms of its measurement ability and
improved spatial awareness let us now examine how these
have been applied in the diagnosis of subfertility and sub-
sequent monitoring of treatment.
Investigation of subfertility
Three-dimensional ultrasound has been used to diagnose
uterine anomalies, assess tubal patency and to exclude
intrauterine and ovarian pathology.
• Uterine anomalies
Congenital uterine anomalies are associated with an
increased risk of repeated first and second trimester mis-
carriage and preterm delivery [19]. A meta-analysis of
published retrospective data comparing pregnancy out-
come before and after hysteroscopic septoplasty indicated
a marked improvement after surgery, which itself has
minimal postoperative sequelae [20]. Accurate and relia-
ble diagnosis is important therefore as it allows the iden-
tification of patients at risk of these complications and
timely surgical intervention. This is undoubtedly the area
where three-dimensional sonography has contributed the
most and has become the investigation of choice in units
where available. This reflects its ability to demonstrate
both the endometrial cavity and the myometrium simul-
taneously in the coronal plane as shown by Jurkovic et al.
in their pioneering study of 61 patients with a history of
recurrent miscarriage or infertility (Figs. 7) [21]. Hystero-
salpingography had shown the presence of a normal
uterus in 44 (72.1%) patients, an arcuate uterus in nine
(14.8%) and a major fusion defect in three cases (4.9%).
Whilst two-dimensional sonography was associated with
five false-positive diagnoses of arcuate uteri and three of
major uterine anomalies, three-dimensional sonography
agreed with hysterosalpingography in all of these cases.
Shortly afterwards Raga et al. and Wu et al. both reported
similarly favourable results suggesting three-dimensional
sonography offered a 100% specificity for the exclusion of
uterine anomalies and was able to differentiate between
the different anomalies [22,23].Journal of Experimental & Clinical Assisted Reproduction 2005, 2:10 http://www.jexpclinassistreprod.com/content/2/1/10
Page 4 of 18
(page number not for citation purposes)
The techniques of volume calculation Figure 2
The techniques of volume calculation. Both figures show the typical multiplanar display of a three-dimensional sonographic 
dataset of the uterus with the three mutually related orthogonal planes at 90-degrees to one another. The upper left image in 
both displays represents the longitudinal plane (the A plane), the upper right image the transverse plane (the B plane) and the 
lower left image the coronal plane (the C plane). Volume calculation can be conducted in either the B or C plane. (a) shows the 
conventional technique of volume calculation in which a series of 'slices' are taken through the volume of interest whilst the 
contour is outlined in another plane (the transverse plane in this case). The distance between consecutive slices can be varied 
according to the degree of change in the surface contour and increased for more complex structures. (b) shows the rotational 
technique of volume calculation in which the dataset is rotated through 180° about a central axis defined by the application of 
two callipers. The number of planes available for volume calculation are determined by the rotation step shown in the lower 
left of the image. Here the 30-degree rotation step has been used and the contour outlined in the coronal or C plane using the 
manual mode. The resultant three-dimensional model is shown in the lower right of the image.
(a)
(b)Journal of Experimental & Clinical Assisted Reproduction 2005, 2:10 http://www.jexpclinassistreprod.com/content/2/1/10
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Three-dimensional sonography has since been used to
determine the prevalence of uterine anomalies in various
patient groups and to characterise outcome on the basis of
the anomaly. As many as 24% of women with recurrent
pregnancy loss may have uterine anomalies [14] which is
roughly four times that seen in low-risk women where the
prevalence is in the order of 5 to 6% [25,26]. In terms of
the type of anomaly a similar distribution is seen between
different groups with arcuate uteri being the most com-
mon, followed by subseptate then bicornuate uteri with
the more complex anomalies such as uterus didelphys
and single uterine horns the least prevalent. Women with
a subseptate uterus have a significantly higher proportion
of first-trimester loss and women with an arcuate uterus a
significantly greater proportion of second-trimester loss
(p < 0.01) and preterm labor (p < 0.01) compared to
women with a normal uterus [24]. Another important
finding derived from these three-dimensional studies has
been that outcome is related not only to the degree of
defect but also to the remaining cavity length which is sig-
nificantly shorter in both arcuate and subseptate uteri in
women with recurrent miscarriage [26]. These measure-
ment techniques and classifications used allow compari-
son between these studies as a degree of standardisation
has been used, based on measurement of fundal distor-
tion from the mid-point of an imaginary horizontal line
joining the upper aspects of the cornuae to the upper
aspect of the uterine cavity, that has been shown to be reli-
able between observers examining stored three-dimen-
sional datasets (Fig. 7f) [27].
If we revisit the advantages proposed at the start of the
review we can see that the majority are already satisfied in
respect to uterine anomalies. Three-dimensional sonogra-
phy offers a reliable and standardised tool to diagnose,
differentiate and quantify uterine anomalies. Three-
dimensional sonography has significantly added to our
Three-dimensional 'wire' models of the endometrium Figure 3
Three-dimensional 'wire' models of the endometrium. When VOCAL is used to calculate volume a three-dimensional model is 
generated that may be rotated and examined in its natural orientation. In this model the coronal view is seen on the left clearly 
demonstrates the fundal defect of an arcuate uterus whilst the actual anteflexion of the uterus may be appreciated in the lateral 
view on the right.Journal of Experimental & Clinical Assisted Reproduction 2005, 2:10 http://www.jexpclinassistreprod.com/content/2/1/10
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understanding of uterine anomalies qualifying their effect
on reproductive outcome and thereby helping the clini-
cian counsel patients accordingly and confidently.
• Intrauterine pathology
La Torre et al. compared three-dimensional sonography
with conventional imaging with and without saline con-
trast in their study of twenty-three patients in whom sub-
sequent hysteroscopy revealed the presence of 16
endometrial polyps [28]. Standard two-dimensional
sonography demonstrated a relatively poor specificity of
only 69.5% suggesting the presence of polyps in 23
patients. This was improved to 94.1% when two-dimen-
sional sonography was used in conjunction with saline
infusion as only 17 patients were then thought to have
polyps. Three-dimensional sonography performed almost
as well diagnosing the presence of polyps in 18 patients
with a specificity of 88.8% and subsequently correctly
identified all 16 polyps when used in conjunction with
saline infusion. A similar improvement in specificity with
three-dimensional sonography has been shown by Sylves-
tre et al. in their study of 209 subfertile patients thought
to have an intrauterine lesion on transvaginal two-dimen-
sional sonography or hysterosalpingography [29]. Using
saline infusion sonography with two-dimensional and
then three-dimensional sonography, 92 patients were
subsequently identified as having a variety of intrauterine
lesions suggesting a sensitivity and specificity of 97% and
11% for two-dimensional sonography, 87% and 45% for
three-dimensional sonography and 98% and 100% for
two-dimensional saline infusion sonography. Of 59
patients that had undergone hysteroscopy, the sensitivity
and positive predictive value of saline infusion sonogra-
phy were 98% and 95% when performed in combination
Three-dimensional power Doppler angiography of the uterine blood supply Figure 4
Three-dimensional power Doppler angiography of the uterine blood supply. A three-dimensional dataset containing 
power Doppler information has been acquired from the uterus. VOCAL has then been used to define the myometrial-
endometrial border and to apply a shell 5 mm outside of that contour to define the sub-endometrium, which can be clearly 
seen to be more vascular than the endometrium itself.Journal of Experimental & Clinical Assisted Reproduction 2005, 2:10 http://www.jexpclinassistreprod.com/content/2/1/10
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with two-dimensional sonography and 100% and 92%
with three-dimensional sonography respectively. The
study clearly demonstrates how simple contrast media
potentially increase the specificity of two-dimensional
sonography as 55% (116 of 209) of patients were found
to have normal cavities following the infusion of saline.
This was largely due to the correct localization of leiomy-
omas as intramural rather than submucosal (54 of 101).
This is extremely important in the clinical setting, as
whilst three-dimensional sonography improves further
on two-dimensional imaging it is not currently available
in all units and its use therefore has significant implica-
tions in terms of cost and training. Saline infusion on the
other hand may be undertaken easily using various dedi-
cated systems or modifications of readily available
cheaper catheters such as a paediatric feeding tube. Figure
8 shows the typical three-dimensional sonography
appearances of endometrial polyps at different stages of
the menstrual cycle whilst Figure 9 demonstrates a sub-
mucous fibroid at three-dimensional saline infusion
sonography.
• Tubal patency
The combination of contrast media and three-dimen-
sional sonography has also been used to assess tubal pat-
ency. Kiyokawa et al. found three-dimensional saline
sonohysterosalpingography was able to demonstrate the
entire contour of the uterine cavity in 96% of cases com-
pared to only 64% cases with conventional X-ray hystero-
salpingography (p < 0.005) and was associated with a
The 'Histogram' Figure 5
The 'Histogram'. The three indices of vascularity have been calculated for the endometrial model together with the mean 
grey value. The Vascularisation Index (VI) reflects the degree of power Doppler information within the model and is consid-
ered as a percentage therefore whilst the Flow Index (FI) and Vascularisation Flow Index (VFI) include information on the mean 
power Doppler signal intensity referenced against a scale from zero to one hundred to indicate the minimal and maximum 
range accordingly.Journal of Experimental & Clinical Assisted Reproduction 2005, 2:10 http://www.jexpclinassistreprod.com/content/2/1/10
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Intra-subject variation in endometrial blood flow Figure 6
Intra-subject variation in endometrial blood flow. The degree of power Doppler information seen within Figure 6a is clearly 
superior to that seen in Figure 6b and this difference is quantifiable through the 'histogram' facility. These images also serve to 
demonstrate how vascularity is independent of morphometry and varies throughout different phases of the menstrual cycle as 
the less vascular homogenous endometrium characteristic of the luteal phase in Figure 6b is of greater volume than that in Fig-
ure 6a, which is the same endometrium at the end of follicular phase.
(a)
(b)Journal of Experimental & Clinical Assisted Reproduction 2005, 2:10 http://www.jexpclinassistreprod.com/content/2/1/10
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Uterine anomalies Figure 7
Uterine anomalies. Three-dimensional sonography has become the 'gold standard' investigation for the diagnosis and exclu-
sion of congenital uterine anomalies. Its extremely high sensitivity and specificity relate to its ability to demonstrate the plane 
coronal perpendicular to the transducer face and in doing so allow visualisation of the fundal contour and comparison of the 
myometrium with the endometrium throughout the uterine length. Figure 7a shows normal cornna with straight contours at 
the upper aspect of the cavity in contrast to the characteristic concave contour seen in arcuate uteri (Fig. 7b) and the deeper 
contour of various length seen in sub-septate uteri (Figs. 7c, 7d & 7e). Any indentation of the fundal contour may also be appre-
ciated in the coronal plane as seen in the multiplanar display in Figure 7f. This uterus had been considered normal with conven-
tional ultrasound, which only provides the longitudinal and transverse views seen in the upper two images, but laparoscopy had 
demonstrated a bulky uterus with a possible fundal defect and a follow-up three-dimensional ultrasound confirmed the pres-
ence of a significant septum. The size of the septal defect can be measured as shown in Figure 7g but may be less important 
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Endometrial polyps Figure 8
Endometrial polyps. Endometrial polyps are best appreciated during the late follicular phase when they can be seen against 
the plump heterogenous endometrium with its characteristic trilaminar pattern may be seen (Fig. 8a). Polyps may also be seen 
towards the end of menses however or at the 'down-regulation' scan when many women are still bleeding (see below) with the 
menstrual fluid acting as an in vivo contrast agent (Fig. 8b). The coronal view may be used to locate the position of intrauterine 
pathology and confirm the presence of individual smaller polyps suitable often confused as large single fibroids with conven-
tional imaging that are suitable for routine polypectomy rather then hysteroscopic resection (Fig. 8c)
(a)
(b)
(c)Journal of Experimental & Clinical Assisted Reproduction 2005, 2:10 http://www.jexpclinassistreprod.com/content/2/1/10
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positive predictive value and specificity of predicting tubal
patency of 100% in 25 unselected infertile patients [30].
Sladkevicius et al. found three-dimensional power Dop-
pler imaging demonstrated free spill almost twice as often
as conventional imaging (114 versus 58 tubes respec-
tively) when used during hysterosalpingo-contrast sonog-
raphy [31]. Sankpal et al. reported less promising results
with the same technique when they reassessed tubal
patency in 15 women who had normal X-ray HSG
examinations within the previous year [32]. An important
distinction was their use of saline rather than a positive
contrast agent but it maybe that the technique has a dis-
tinct learning curve and numbers were small.
• Polycystic Ovaries
Several groups have used three-dimensional sonography
to demonstrate ovarian volume and vascularity are
increased in polycystic ovarian syndrome [33,36]. Three-
dimensional sonography also allows for the measurement
of stromal volume through the calculation and subtrac-
tion of total follicular volume from total ovarian volume
(Fig. 10). Using this technique Kyei-Mensah et al showed
stromal volume was positively correlated with serum
androstenedione concentrations (p < 0.01) in 26 women
with clinical evidence of polycystic ovaries [37]. However,
using a similar approach, Nardo et al. were unable to
demonstrate any relationship between serum FSH, LH or
testosterone and ovarian stromal volume in 23 infertile
women with clomiphene citrate-resistant PCOS at the
same stage of the menstrual cycle [38].
Assisted reproduction treatment
Transvaginal sonography is used on a daily basis to mon-
itor the response to treatment and to guide the transvagi-
nal collection of oocytes and subsequent transcervical
transfer of embryos to the uterus. Three-dimensional
sonography may be used in any of these areas but has
largely been applied as a predictor of ovarian response
and as a determinant of endometrial receptivity. To clarify
the current evidence in relation to the role of three-dimen-
sional sonography in these areas it is necessary to first out-
line the general principles involved in assisted
reproduction treatment.
• Principles of in vitro fertilisation therapy
The first stage is to obtain control over the hypothalamic-
pituitary-ovarian axis through the induction of pituitary
'down-regulation' achieved through a continuous and
highly supraphysiological dose of a gonadotrophin releas-
ing hormone (GnRH) analogue. Follicular development
is then induced through the administration of natural or
synthetic Follicle Stimulating Hormone (FSH) until at
least three large follicles measuring 18 mm or more are
present when the resumption of meiosis is initiated
though a single dose of human Chorionic Gonadotrophin
Three-dimensional saline infusion contrast sonography Figure 9
Three-dimensional saline infusion contrast sonography. 
Two-dimensional ultrasound had shown a persistently thick 
endometrium despite several weeks of pituitary suppression 
prior IVF treatment and saline infusion sonography has 
proven unhelpful simply confirming a thick endometrium 
despite very low serum oestradiol levels. A three-dimen-
sional acquisition was undertaken therefore both before (Fig. 
9a) and during the instillation of saline (Fig. 9b) and subse-
quently analysed off-line to reduce the amount of saline used 
and overall time needed for the examination. A large sub-
mucosal leiomyoma with a broad base was seen originating 
from the left posterior aspect of the uterus that almost 
entirely occupied the cavity (Fig. 9b). This allowed the cancel-
lation of the planned IVF treatment with the patient continu-
ing her 'down-regulation' medication for a further two-
months at which stage the fibroid was removed transcervi-
cally using a modified operative hysteroscope.
(a)
(b)Journal of Experimental & Clinical Assisted Reproduction 2005, 2:10 http://www.jexpclinassistreprod.com/content/2/1/10
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Polycystic ovaries Figure 10
Polycystic ovaries. Three-dimensional sonography facilitates objective assessment of the ovarian stroma, through measure-
ment of its mean grey signal intensity, its vascularity and its volume, which may be calculated by subtracting total follicular vol-
ume from total ovarian volume (Fig. 9A). Ovarian blood flow is increased and associated with significantly higher three-
dimensional indices of vascularity than ovaries with a normal appearance (Fig. 10b).
(a)
(b)Journal of Experimental & Clinical Assisted Reproduction 2005, 2:10 http://www.jexpclinassistreprod.com/content/2/1/10
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(hCG), which has a similar structure and pharmacody-
namic effect to Luteinising Hormone (LH) but is more
readily available. Exposure to hCG is essential prior to the
collection of the oocytes to ensure that they are mature
and therefore capable of being fertilised when incubated
with sperm during in vitro fertilisation (IVF) or when
injected with a single sperm in intracytoplasmic sperm
injection (ICSI) treatment. This would eventually lead to
ovulation  in vivo if the oocytes were not physically
retrieved and this procedure is critically timed therefore to
occur within 34 to 36 hours of the administration of hCG.
The dose and duration of FSH treatment is dependent
upon each individual patients response to stimulation
and is adjusted dynamically during treatment dependent
on the number of follicles developing and on the amount
of oestrogen they produce collectively as measured in the
serum. The response and eventual number of mature
oocytes retrieved is referred to as the patients 'ovarian
reserve'. Prediction of ovarian reserve has obvious impor-
tance as it allows treatment to be tailored to the individual
potentially increasing the number of oocytes retrieved.
Fertilisation of an oocyte is confirmed by the presence of
two pronuclei 18 to 24 hours after IVF or ICSI. The
embryos are allowed to develop in vitro until the second
or third day after oocyte retrieval when most units would
transfer a maximum of two to the recipient uterus selected
on the basis of their quality as determined by a subjective
grading system. The chance of the implantation occurring
is not only dependent upon the embryo stage and grade
but also on the endometrium. Just how important
'endometrial receptivity' is in the overall process remains
uncertain but the endometrium is likely to play more than
a passive role.
With a better understanding of processes involved in con-
trolled ovarian stimulation and assisted reproduction let
us now turn to the application of three-dimensional
sonography and critically review its current role.
• Three-dimensional markers of 'ovarian reserve'
Of the sonographic markers suggested as predictive of
ovarian response the three that have been specifically
addressed by three-dimensional sonographic studies are
antral follicle counts, ovarian volume and ovarian blood
flow.
Pellicer et al. were amongst the first to use three-dimen-
sional sonography as an adjunct to conventional markers
of ovarian reserve when they examined ovarian volume
and the number of 'selectable follicles' measuring 2–5
mm in a small group of low responders on day three of
the menstrual cycle [39]. Both the number of selectable
follicles and the total number of antral follicles were
significantly decreased in the 'low responder' group who
also demonstrated significantly higher serum FSH levels
despite having values within the normal range. Ovarian
volume measurements, however, were similar between
the two groups. Pohl et al. also used three-dimensional
sonography to quantify the number of follicles of varying
diameter in 113 patients following 'down-regulation' but
prior to ovarian stimulation ([40]. Patients with a higher
number of follicles measuring between 5 and 10 mm were
younger (p < 0.01), had a significantly higher number of
oocytes retrieved (p < 0.0001) and were more likely to
conceive (p < 0.05) (Fig. 12). Kupesic et al also suggest
that the antral follicle count is a better predictor than
three-dimensional measures of ovarian volume and
blood flow [41]. A minimal ovarian volume may be
important however (Fig. 11). Schild et al. noted a preg-
nancy rate of only 6.7% (1 of 15) in patients with a mini-
mum unilateral ovarian volume of ≤ 3 cm3, which
represented a single standard deviation below the mean,
versus 21.9% (30 of 137) in patients with an initial mini-
mum ovarian volume above 3 cm3[42]. This difference
was not significant however and cancellation rates due to
poor ovarian response or failed fertilisation were similar
in both groups.
There is no doubt that antral follicle counts, when used in
categorical classifications, are an important predictor of
'ovarian reserve' and may be measured with a high level of
agreement both between and within observers [43]. Tree-
dimensional sonography, however, does not appear to
offer any significant advantage over two-dimensional
imaging even at higher follicle counts when interobserver
reliability is reduced. Ovarian volume has a limited
predictive ability that does not appear to supersede that of
antral follicle counts. Do measurements of ovarian vascu-
larity add anything to validate the use of three-dimen-
sional sonography as a marker of ovarian reserve?
Jarvela et al. used three-dimensional power Doppler ang-
iography after pituitary 'down-regulation' and during
gonadotrophin stimulation to compare ovarian vascular-
ity in 33 women with normal ovarian reserve, as judged
by antral follicle counts, to 12 women who had demon-
strated a previous poor response [44]. The number of
oocytes retrieved correlated with the antral follicle count
(R = 0.458, p < 0.01) and ovarian volume (R = 0.388, p <
0.05) but not with ovarian vascularity. All three indices of
vascularity were shown to increase significantly during
gonadotrophin stimulation in the group with normal
ovarian reserve only but this was related to the antral fol-
licle count reiterating the importance of this marker as an
independent variable. Kupesic et al. similarly showed the
number of oocytes retrieved and subsequent conception
rate to be greater in patients with a greater ovarian volumeJournal of Experimental & Clinical Assisted Reproduction 2005, 2:10 http://www.jexpclinassistreprod.com/content/2/1/10
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and a greater ovarian stromal vascularity but not inde-
pendently of a higher number of antral follicles [45].
• Three-dimensional markers of 'endometrial receptivity'
Schild et al. measured endometrial thickness and volume
in a total of 47 IVF cycles on the day of oocyte retrieval
[46]. There were no significant differences between the
group of fifteen patients that conceived (31.9%) and the
remaining 32 non-pregnant women in terms of the mean
endometrial thickness (10.8 ± 2.3 mm versus 11.8 ± 3.4
mm) or volume (4.9 ± 2.2 cm3 versus 5.8 ± 3.4 cm3)
respectively. Yaman et al. reported similar findings with
no differences in endometrium volume (4.16 ± 1.97 cm3
versus 4.53 ± 1.79 cm3), endometrium thickness (11 ± 2
mm versus 11 ± 2 mm) between 21 pregnant and 44 non-
pregnant women on the day of hCG administration [47].
However, whilst there was no absolute endometrial thick-
ness required for pregnancy a minimal endometrial vol-
ume above 2.5 cm3 favoured pregnancy. Raga et al. also
described a cut-off point in endometrial volume in their
study of 72 patients on the day of embryo transfer [48].
Implantation rates were significantly lower (p < 0.05) in
those women with endometria measuring less than 2 cm3
and no pregnancies were observed at volumes below 1
cm3. Even if there is a lower limit in endometrial volume
below which pregnancy will not occur conventional
measurement of endometrial thickness is already known
to have a similar negative predictive value with concep-
tion less likely in patients with an endometrium measur-
ing less than 5 mm in diameter.
Kupesic et al. reported more predictive information could
be derived at the time of embryo transfer when three-
dimensional power Doppler was used to quantify
Ovarian volume calculation Figure 11
Ovarian volume calculation. Ovarian volume may be measured in the same way as endometrial volume through the manual 
delineation of the ovarian cortex.Journal of Experimental & Clinical Assisted Reproduction 2005, 2:10 http://www.jexpclinassistreprod.com/content/2/1/10
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Controlled ovarian stimulation Figure 12
Controlled ovarian stimulation. Three-dimensional sonography may be used to facilitate standard measurement of follicular 
diameter (a). During the latter stages of ovarian stimulation the ovaries may contain many follicles, which become progres-
sively harder to measure reliably between observers, as there are no landmarks to aid orientation. Off-line analysis of stored 
three-dimensional datasets reduces the time spent with the patient and may potentially improve the number of mature oocytes 
retrieved by identifying the most appropriate time for oocyte collection. Evidence also suggests that three-dimensional render-
ing allows demonstration of the cumulus oophorus complex in follicles containing a mature oocyte (b).
(a)
(b)Journal of Experimental & Clinical Assisted Reproduction 2005, 2:10 http://www.jexpclinassistreprod.com/content/2/1/10
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endometrial vascularity [49]. Of 89 patients studied suc-
cessful conception cycles were associated with a signifi-
cantly higher endometrial flow index (13.2 ± 2.2 versus
11.9 ± 2.4, p < 0.05). Wu et al. also found three-dimen-
sional power Doppler angiography to be an important
determinant of 'endometrial receptivity' but on the day of
hCG administration in 54 patients undergoing their first
IVF cycle [50]. The subendometrial vascularisation flow
index (VFI) proved the best predictor of conception being
superior to the vascularisation index (VI), flow index (FI)
and endometrial volume in the receiver operating charac-
teristics curve analysis. Interestingly, three-dimensional
sonography may also be used to examine endometrial
vascularity and determine 'endometrial receptivity' prior
to ovarian stimulation. Schild et al. reported significantly
lower indices of vascularity at down-regulation in 15
patients that subsequently conceived (20%) than in 60
non-conception cycles (p < 0.05) with the flow index the
strongest predictive factor of IVF success (p < 0.05) [51].
Endometrial measurements were once again not corre-
lated with outcome. This may reflect a more profound
pituitary suppression but is more likely to reflect patients
responsive to exogenous hormonal therapy.
Applications in early pregnancy
• Miscarriage
Gestational sac volume has been proposed as representa-
tive of the competence of the early uteroplacental unit and
therefore a potential predictor of pregnancy outcome
[52]. In one of the first reported applications of three-
dimensional sonography, Steiner et al. studied 38 preg-
nancies between 5 and 11 weeks gestation and found
gestational sac volume measurements to significantly cor-
related with gestational age (r = 0.74, p < 0.001) and more
than two standard deviations below the mean in three of
five embryonic or anembryonic pregnancy failures [52].
However, Acharya and Morgan have recently shown a
clear relationship between gestational sac volume and sac
diameter also exists in patients with embryonic pregnancy
failure and that measurements are unable to predict even-
tual outcome during conservative management [53]. Bab-
inszki et al. did find a relationship between gestational sac
and yolk sac volume and adverse outcome in a group of
49 patients who had conceived following treatment for
subfertility but crown rump length performed equally as
well [54].
Currently, therefore, one may conclude that whilst there is
a distinct relationship between gestational age and three-
dimensional measurements of gestational and yolk sac
volume, these parameters do not appear to improve upon
the predictive value of current tests in determining the
eventual outcome in either viable or non-viable intrauter-
ine pregnancies.
• Ectopic pregnancy
The improved spatial orientation afforded by three-
dimensional sonography has been used to evaluate
endometrial shape in cases of pregnancy of unknown
location in an attempt to improve the sensitivity and
specificity of sonography. Rempen et al. described the per-
sistence of a distinct symmetry with regard to the median
longitudinal axis of the uterus in the coronal plane in 90%
of extrauterine pregnancies which was lost in intrauterine
pregnancies [55]. Su et al. reported a case of an anembry-
onic cervical pregnancy diagnosed at 10 weeks associated
Ectopic pregnancy Figure 13
Ectopic pregnancy. The spatial orientation of three-dimen-
sional ultrasound and its ability to demonstrate the coronal 
plane of the uterus in its natural position may help in the 
diagnosis and exclusion of ectopic pregnancy. This is particu-
larly true in cases of heterotropic pregnancy where an intra-
uterine pregnancy is associated with an ectopic twin 
gestation. Spontaneous heterotropic pregnancy is rare but 
may complicate 0.5% of pregnancies arising from IVF treat-
ment with the ectopic gestation located in the cornua (Fig. 
13a) or cervix (Fig. 13b).
(a)
(b)Journal of Experimental & Clinical Assisted Reproduction 2005, 2:10 http://www.jexpclinassistreprod.com/content/2/1/10
Page 17 of 18
(page number not for citation purposes)
with a large arteriovenous malformation managed
conservatively with selective uterine artery embolisation
[56]. Three-dimensional power Doppler ultrasonography
proved useful in the initial diagnosis subsequent
monitoring of the response to treatment. These studies
suggest a potential role for three-dimensional sonography
but in the absence of properly blinded data it is impossi-
ble to predict whether it will improve upon conventional
sonography. The spatial orientation and additional infor-
mation afforded by the coronal plane do lend themselves
to assessment of the endometrial cavity as illustrated so
elegantly by the three-dimensional studies on uterine
anomalies so one should be optimistic in this regard. Cer-
tainly in our own unit we have found three-dimensional
imaging to be beneficial in several cases of pregnancy of
unknown location and particularly so in twin pregnancies
following assisted reproduction treatment and embryo
transfer where heterotropic pregnancy is so much more
likely (Fig. 13).
Conclusion
There is sufficient evidence to support the notion that the
theoretical advantages of three-dimensional sonography
are indeed translated into clinical practice in the field of
reproductive medicine. The spatial orientation and addi-
tional information derivable from individual sectional
planes has greatly enhanced our knowledge of uterine
anomalies and contributed to our understanding of how
these affect pregnancy outcome and may offer insight into
the location of pregnancies of unknown location.
Quantitative three-dimensional analysis of volume and
vascularity has proven less powerful and whilst individual
studies suggest a potential role for such measurements
these do not appear to out perform current assessments.
For now three-dimensional sonography largely remains
an exciting research tool with the converted applying it in
different forms and areas of interest and in doing so
unearthing significant new information about normal
physiology and pathophysiological change that direct fur-
ther work. Three-dimensional sonography offers too
much to be ignored and, as history has shown with
previous developments, will gradually become common-
place in most units. Our role is to continue to test it
prospectively but to remain realistic and to examine how
it may be most appropriately applied in the clinical set-
ting. Be a pioneer, embrace it and you will be rewarded
handsomely!
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